Newsroom

News
The focus will be on the well-being of patients and protection of their privacy. The new Helmholtz Medical Security, Privacy and AI Research Center (HMSP) brings together researchers from the fields of IT security, data protection, artificial intelligence and medicine. Together they will develop solutions for individualised medicine, among other projects.
23.05.2019
Markus Cornberg
Interview
Markus Cornberg, a medical doctor by training, is the new Clinical Director of the Helmholtz Centre for Infection Research (HZI) and heads the Centre for Individualised Infection Medicine (CiiM) in Hannover. He took up this role on 1 January 2019, succeeding Michael Manns, who has taken over the presidency at Hannover Medical School (MHH). In an interview, Cornberg talks about the initial steps towards individualised infection medicine that takes into account the specific characteristics of individual patients or patient groups.
06.05.2019
Portrait of Thomas Pietschmann, TWINCORE
Interview
About 70 million people worldwide are chronically infected with the hepatitis C virus (HCV). Possible consequences include hepatitis, cirrhosis and liver cancer, but the disease often remains undetected for long periods of time. Thomas Pietschmann of the TWINCORE in Hannover investigates the virus and works on the development of a vaccine that could prevent HCV infections in the future.
01.05.2019
Portrait of Alice McHardy
Portrait
Alice McHardy reveals how she came to bioinformatics and what fascinates her about her work with massive volumes of data.
01.05.2019
Upper arm vaccination
Story
Carlos A. Guzmán's research team applies knowledge about the human immune system and its challengers to develop innovative vaccination strategies.
01.05.2019
Stereomicroscopic image of Cystobacter violaceus in red.
Story
Among all the hospital germs, Gram-negative bacteria are particularly difficult to treat: Many antibiotics fail due to the double-cell membrane. But cystobactamides are providing hope for a remedy – substances from the extensive collection of bacteria held by the HZI. These bacteria are going to be further developed into drugs in a partnership with the pharmaceutical company Evotec.
01.05.2019

HZI in the media

Die Schüler vom Greifswalder Alexander-von-Humboldt Gymnasium forschen in diesem Schuljahr zusammen mit Forschern ...

01.07.2024
|
Tagesschau

Sendung: NDR Info | 01.07.2024 | 14:00 Uhr

01.07.2024
|
NDR Norddeutscher Rundfunk

Um Viren für Impfstoffe zu inaktivieren, werden oft Gammastrahlen verwendet. Forscher aus Darmstadt und Braunschweig ...

30.06.2024
|
FAZ.NET

Für Neugeborene ist RSV lebensgefährlich, Winterkinder sollen auf der Entbindungsstation Antikörper bekommen © Getty Images Für ...

28.06.2024
|
MSN Deutschland

Neuer Ansatz zur DNA-Transformation und Genmutation in Bakterien entwickelt: Grundlage für neue Antibiotika und ...

28.06.2024
|
Bionity.COM

Respiratorische Synzytial-Viren (RSV) sind eine bedeutende Ursache für Atemwegsinfektionen, insbesondere bei Säuglingen und älteren ...

27.06.2024
|
ScienceMediaCenter